Orchid Asia, Eastern Bell in Series B for China’s Weimeizi

The funding amounts to several hundred million renminbi, according to a release. The company raised an undisclosed Series A round from Legend Capital in September of last year.

Founded in 2006, Guangzhou-based Weimeizi manufactures a wide range of oral care products from toothbrushes to dental gross under its own Saky brand. The company is also an original equipment manufacturer (OEM) for more than 13 domestic brands. It claims to produce a total of 26,000 tons of toothpaste and 13.2 million toothbrushes every month.

The company has built a sale network in more than 300 Chinese cities and distributes its products distributed through Carrefour, Wall-Mart, Jusco and other supermarkets.

"We choose to invest in Weimeizi is because the company's Saky products have stood out from the market even it's extremely competitive," representatives from Orchid Asia and Eastern Bell Ventures said in the release.

Orchid Asia closed its sixth China growth capital fund at the hard cap of $920 million in August 2014. The firm focuses on backing experienced operating executives in building franchises in Asia, with an emphasis on China. Sectors of interest include consumer products and services as well as outsourced manufacturing and services.

Eastern Bell Ventures was founded in 2009 and focuses on logistics, supply chain, consumer and retail, as well as online-to-offline (O2O) e-commerce companies. It manages two renminbi-denominated funds, with CDB Capital and Oriza Holdings among the LPs.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Save this article  
• Send to  

• Topics
• Greater China
• Consumer
• Expansion
• China
• Orchid Asia Group Management
• Growth capital
• Consumer